Safety and feasibility of performing two consecutive ovarian stimulation cycles with the use of letrozole-gonadotropin protocol for fertility preservation in breast cancer patients
about
In vitro maturation of human oocytes: Its role in infertility treatment and new possibilitiesCurrent state and controversies in fertility preservation in women with breast cancer.Ovarian tissue cryopreservation followed by controlled ovarian stimulation and pick-up of mature oocytes does not impair the number or quality of retrieved oocytesSexual dysfunction and infertility as late effects of cancer treatment.Fertility preservation in women with cancer.Fertility preservation and breast cancer: a reviewOvarian stimulation in patients with breast cancerFertility Preservation Success Subsequent to Concurrent Aromatase Inhibitor Treatment and Ovarian Stimulation in Women With Breast CancerIVF for fertility preservation in breast cancer patients--efficacy and safety issuesThe safety and efficacy of controlled ovarian hyperstimulation for fertility preservation in women with early breast cancer: a systematic review.Oncofertility program implementation increases access to fertility preservation options and assisted reproductive procedures for breast cancer patients.An overview of pregnancy and fertility issues in breast cancer patients.Freezing oocytes or embryos after controlled ovarian hyperstimulation in cancer patients: the state of the art.Fertility preservation in women with CNS tumors.The past, present and future of fertility preservation in cancer patients.Progesterone levels in letrozole associated controlled ovarian stimulation for fertility preservation in breast cancer patients.Cancer and fertility preservation: international recommendations from an expert meeting.Fertility preservation for medical reasons in girls and women: British fertility society policy and practice guideline.Advances in fertility preservation of female patients with hematological malignancies.Ovarian Stimulation in Patients With Cancer: Impact of Letrozole and BRCA Mutations on Fertility Preservation Cycle Outcomes.State-of-the-art fertility preservation in children and adolescents undergoing haematopoietic stem cell transplantation: a report on the expert meeting of the Paediatric Diseases Working Party (PDWP) of the European Society for Blood and Marrow TranFertility preservation for patients with breast cancer: The Korean Society for Fertility Preservation clinical guidelines.Vitrification of embryos and oocytes for fertility preservation in cancer patients.Fertility Preservation for Patients with Malignant Disease. Guideline of the DGGG, DGU and DGRM (S2k-Level, AWMF Registry No. 015/082, November 2017) – Recommendations and Statements for Girls and Women.Motherhood after breast cancer: can we balance fertility preservation and cancer treatment? A narrative review of the literatureEffects of controlled ovarian stimulation on toxicity of TAC chemotherapy in early breast cancer patientsRecent advances in oncofertility care worldwide and in Japan
P2860
Q26822425-8E45D9CF-5DE5-4139-B806-D01E9388E0AFQ33779879-22FB3233-E393-44AB-84BA-10F11E61ADE5Q34157016-EEFB6AAF-B919-4D5E-9446-852D459EFB51Q34604454-29ADE2A7-9792-4230-B1BC-2B05BB3E4A65Q34729392-3FAC47F4-B9E6-4C6E-AC4F-77C291A91B57Q35106163-BF9CF36A-8F0D-4A99-BE37-187FD3554D3FQ35106191-E6EDCFAB-5B05-484F-A232-32F49001573BQ35866348-DB4FFEBA-5364-4785-9409-A291003C2074Q36010271-DFA300A8-3F67-4D90-A227-21B5B400947AQ36319447-9EDCE1D3-B210-4D5A-9674-E425F6A8E926Q37625041-F5B7CD40-CCB6-4E24-B3FA-85A214059C81Q38626663-C38BC6A3-7EAC-46B9-865D-4C636C77AD3FQ38835475-AF05F9A1-E6CF-480F-8363-DFFE27AB7CE2Q38843979-7680A6D2-C9E4-4B13-860B-CC6BD096411DQ38965305-3ABE4F30-6BEE-4B6D-A5B4-B3295A1D52D6Q40799076-56A6E44C-4958-4BBE-83D1-DBB7C292FF70Q43106184-BF3FAF92-3FD5-47BD-AC5E-CD9BCE7B9BBAQ47558016-025730AF-C9CC-4334-92EC-9E40D54E3DEFQ47662579-39278281-6DDA-4287-B620-D49A17773E4CQ48032298-42A40D24-23E7-4698-86C8-8108F152AC38Q48135567-DC792F10-69F2-45C4-8C4F-071AE849C002Q48502529-E7A8F0E2-85F5-4683-921B-9835B96EC649Q48556557-E7BDC8F1-25F3-415E-B3B9-43899E18DAF5Q55361437-671C63C7-6061-481D-93E1-14D0C655D72BQ57107180-395CA7CF-242A-4592-8F29-DBAD50475025Q57491312-59FC7EFB-0656-4C41-AA1D-C53BED74018FQ58130959-A8BA169A-0BED-472B-9005-B0D45F32CF15
P2860
Safety and feasibility of performing two consecutive ovarian stimulation cycles with the use of letrozole-gonadotropin protocol for fertility preservation in breast cancer patients
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 19 September 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Safety and feasibility of perf ...... tion in breast cancer patients
@en
Safety and feasibility of perf ...... ion in breast cancer patients.
@nl
type
label
Safety and feasibility of perf ...... tion in breast cancer patients
@en
Safety and feasibility of perf ...... ion in breast cancer patients.
@nl
prefLabel
Safety and feasibility of perf ...... tion in breast cancer patients
@en
Safety and feasibility of perf ...... ion in breast cancer patients.
@nl
P2093
P2860
P1476
Safety and feasibility of perf ...... tion in breast cancer patients
@en
P2093
Giuliano Bedoschi
Kutluk Oktay
Volkan Turan
P2860
P304
P356
10.1016/J.FERTNSTERT.2013.08.030
P407
P577
2013-09-19T00:00:00Z